Iron supplement

Feb 19, 2020

New Data Show Oral Ferric Maltol (FERACCRU®) May Be a Cost-effective Alternative to Intravenous (IV) Carboxymaltose With at Least as Great Benefits in the Quality of Life of Patients With Iron Deficiency Anaemia and Inflammatory Bowel Disease

Feb 10, 2020

Pharmacosmos Therapeutics Inc. established as a new specialty pharmaceutical company to bring recently approved treatment option to iron deficiency anemia patients

May 30, 2019

$7.69 Bn IV and Oral Iron Drugs Markets - Global Outlook and Forecast 2019-2024

May 22, 2019

The Global IV and Oral Iron Drugs Market is Expected to Reach Around $7.69 Billion During Forecast Period 2018-2024-Market Research by Arizton

Mar 04, 2019

Important New Trial With Oral FERACCRU® Shows Comparable Efficacy to IV Iron (Ferric Carboxymaltose), Offering a Real Alternative to Hospital Administration for Many Patients[4]

Dec 06, 2018

Clinical trial sheds new light on potential risk associated with intravenous iron treatment

Nov 15, 2018

Intravenous (IV) Iron Drugs: The Global Market is Projected to Grow Tremendously During 2018-2022

May 15, 2018

Alcyon Health family planning and iron supplements for men and women coming to health and beauty e-commerce site VitaBeauti.com

Oct 23, 2017

Global Intravenous (IV) Iron Drugs Market, 2024 - Increasing Trend towards Bundled Reimbursements